Conforma
Sources: the KBO register on 17-11-2026; the National Bank, 2025 annual accounts filed on 30-07-2026; the Belgian Official Gazette, latest deed of 18-11-2024.
Grounds
the facts the verdict rests on, each with its source- In 2025, Conforma closed with a net profit of €1.6m, the highest profit since 2006.Annual accounts 2025 page 2
- Equity stands at €4.1m, or 25.0% of the balance sheet total of €16.3m. That is more than 86% of the 84 companies in the pharmaceuticals sector (NACE 21).Annual accounts 2025 page 2
- A mortgage of €2.0m rests on the company's own assets.Annual accounts 2025, notes page 2
- The 2025 accounts came in 1 day before the end of the term; the 2024 accounts 41 days late.National Bank, filing of 30-07-2026 page 5
- (0451.906.964) holds 99% of the shares. Its equity stood at €11.9m on 31-12-2025. That parent has 2 direct subsidiaries in 2 countries.Annual accounts 2025 of page 4
Representation
The signing rule is in the deed of 02-04-2024.
Articles of association, Belgian Official Gazette of 02-04-2024, deed 24054122
Ownership
(0451.906.964) holds 99% of the shares. Its equity stood at €11.9m on 31-12-2025.
Annual accounts 2025 of
Financial situation
Annual accounts 2021 to 2025, as filed with the National Bank
Gross margin and net resultin €m
Equity and debtsin €m
Cashin €m
| Financial year | 2021 | 2022 | 2023 | 2024 | 2025 | Trend |
|---|---|---|---|---|---|---|
| Results | ||||||
| Gross margin | €4.2m | €5.1m | €7.0m | €7.0m | €8.9m | |
| Operating result | -€722,172 | -€860,833 | €260,320 | -€430,977 | €1.9m | |
| Net result | -€849,353 | -€1.0m | €64,797 | -€463,894 | €1.6m | |
| Balance sheet at the closing date | ||||||
| Equity | €3.9m | €2.8m | €2.9m | €2.4m | €4.1m | |
| Debts | €7.5m | €9.9m | €10.6m | €9.5m | €12.2m | |
| Debts due after more than one year | €3.7m | €3.4m | €3.0m | €2.7m | €3.6m | |
| Debts due within one year | €3.8m | €6.6m | €7.6m | €6.8m | €8.6m | |
| Cash | €367,525 | €446,876 | €1.1m | €815,931 | €2.8m | |
| Balance sheet total | €11.4m | €12.8m | €13.5m | €11.9m | €16.3m | |
| Operations | ||||||
| Employees in full-time equivalents | 77.6 | 78.9 | 88.4 | 99.7 | 97.0 | |
| Ratios | ||||||
| Solvency | 33.8% | 22.2% | 21.5% | 20.5% | 25.0% | |
| Liquidity | 1.42 | 1.15 | 1.11 | 1.10 | 1.16 | |
| From the notes | ||||||
| Debts secured on the company's own assets | €1.4m | €2.7m | €2.5m | €2.3m | €4.2m | |
Source: Annual accounts 2025, abbreviated format, filed on 30-07-2026 (2026-00370867); Annual accounts 2024, abbreviated format, filed on 10-09-2025 (2025-00489653); Annual accounts 2021 to 2023, filed from 26-12-2022 to 12-07-2024 (2022-20548324, 2023-00515390, 2024-00245923).
Debts rose by €2.7m in 2025, of which €102,499 to suppliers.
€4.2m of the debt is secured on the company's own assets; in 2024 it was €2.3m.
The 2025 annual accounts state no amount of overdue tax or social security (RSZ) debts.
Board, signature and ownership
Position on 17-11-2026 according to the deeds in the Belgian Official Gazette and the annual accounts
Who represents the company
The signing rule is in the deed of 02-04-2024.
Articles of association, Belgian Official Gazette of 02-04-2024, deed 24054122
Board
four directors and one statutory auditor in officealso sits on the board of 1 other company. also sits on the board of 1 other company. also sits on the board of 1 other company. also sits on the board of 1 other company.
Ownership and group
Shareholders
(0451.906.964) holds 99% of the shares. Its equity stood at €11.9m on 31-12-2025.
Annual accounts 2025 of
Board changes
(managing director), , and reappointed. , , , and act as permanent representatives. appointed as statutory auditor. General meeting of 27-06-2024.
Gazette, deed 24162839(managing director), , , and (statutory auditor) reappointed. , , and act as permanent representatives. appointed as managing director. General meeting of 25-10-2021.
Gazette, deed 22031743appointed as director. acts as permanent representative. General meeting of 23-09-2019.
Gazette, deed 20050165(managing director), and reappointed. , and act as permanent representatives. appointed as statutory auditor. General meeting of 26-08-2019.
Gazette, deed 19142172Group
has 2 direct subsidiaries in 2 countries (2025 accounts).
| Country | Company | Equity | Result | |
|---|---|---|---|---|
| Belgium 1 | ||||
| BE | Conformathis company99% | €4.1m | result €1.6m | |
| North America 1 | ||||
| US | USD 146,863 | result USD 143,247 | ||
Source: List of holdings in the 2025 accounts of . Holdings that file themselves stand with their latest accounts, the others with the amounts of that list, in their own currency.
Events and comparison
The last 24 months, newest first
Annual accounts 2025 filed, 1 day before the deadline.
NBB filingBack to profit. The net result is €1.6m, after one loss-making year.
FinancialAnnual accounts 2024 filed, 41 days late.
NBB filing(managing director), , and reappointed. , , , and act as permanent representatives. appointed as statutory auditor. General meeting of 27-06-2024.
Gazette, deed 24162839Comparable companies, two years later
In July 2024, 378 companies had the same profile as Conforma has now: medium-sized, 20 years or older, solvency 10 to 30% and a profit of 5% of the balance sheet or more. Two years later 97.4% were still trading, 2.4% had stopped another way and 0.3% had gone bankrupt.
In 2025, Conforma had a higher net result than 95% of the 84 companies in the pharmaceuticals sector (NACE 21).
Other findings
Peppol
Reachable for e-invoices, under 0208:0400131235.
Sanctions lists
Staff
106 employees on 31-12-2025, 97.0 full-time equivalents on average over the year.
Sources and method
Where each fact in this report comes from
| Source | What | Date | Reference |
|---|---|---|---|
| KBO register | Registration, legal situation, activity, establishment units | 17-11-2026 | KBO 0400.131.235 |
| National Bank of Belgium | Annual accounts 2025, abbreviated format | 30-07-2026 | 2026-00370867 |
| National Bank of Belgium | Annual accounts 2024, abbreviated format | 10-09-2025 | 2025-00489653 |
| National Bank of Belgium | Annual accounts 2021 to 2023 | 26-12-2022 to 12-07-2024 | 2022-20548324, 2023-00515390, 2024-00245923 |
| Belgian Official Gazette | Board | 18-11-2024 | deed 24162839 |
| Belgian Official Gazette | Articles of association with the signing rule | 02-04-2024 | deed 24054122 |
| Belgian Official Gazette | Board | 08-03-2022 | deed 22031743 |
| Belgian Official Gazette | Board | 16-04-2020 | deed 20050165 |
| Peppol Directory | Registration for e-invoices | 0208:0400131235 | |
| Sanctions lists EU, UN, US (OFAC) and UK | Comparison of the name | 16-11-2026 | no match |
| Checked | Checked score, bankruptcy probability, credit, comparable companies | 16-11-2026 | bankruptcy model of 2 October 2026 |
Method
Checked score. A number from 0 to 100. The bankruptcy probability sets the class, from Critical to Excellent; within the class, the comparison with sector peers on solvency, liquidity, profitability and growth counts for half.
Bankruptcy probability. The probability that the company goes bankrupt within 12 months, estimated from the KBO register, the annual accounts and the Gazette with the bankruptcy model of 2 October 2026, computed on 16-11-2026.
Credit. The credit is a tenth of equity, weighted by the score, and never more than a tenth of turnover. With negative equity there is no credit.
Payment terms. Supplier credit is the debt to suppliers divided by the year's purchases, times 365. Customer credit is the same for what customers still owe, against turnover.
Comparable companies. Companies of the same size, age, solvency and profitability at an earlier date, followed two years later in the KBO register and the Gazette.
The scores and ratios are Checked's own calculations, not a credit decision.